Johnson & Johnson: Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024
November 05, 2024
November 05, 2024
NEW BRUNSWICK, New Jersey, Nov. 5 (TNSres) -- Johnson and Johnson issued the following news release:
* * *
Novel Intravascular Lithotripsy (IVL) catheter demonstrates ability to modify calcium safely, enabling treatment and crossing of tightly-stenosed lower limb lesions
Technology has received U.S. FDA clearance for patients with peripheral arterial disease
* * *
LAS VEGAS, November 4, 2024 - Shockwave Medical, Inc., part of Johns . . .
* * *
Novel Intravascular Lithotripsy (IVL) catheter demonstrates ability to modify calcium safely, enabling treatment and crossing of tightly-stenosed lower limb lesions
Technology has received U.S. FDA clearance for patients with peripheral arterial disease
* * *
LAS VEGAS, November 4, 2024 - Shockwave Medical, Inc., part of Johns . . .